The Woodbridge Company’s Medtronic MDT Stock Holding History

The Woodbridge Company’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-63,885	Closed	-$6.14M	–	61
2025 Q4	$6.14M	Buy	+63,885	New	+$6.21M	0.02%	27

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

The Woodbridge Company's MDT Position: Q1 2026 in Review

The Woodbridge Company sold out of Medtronic (MDT) in Q1 2026, closing a stake of 63,885 shares — an estimated $6.14M sold.

The Woodbridge Company first reported a position in MDT in Q4 2025 and held it in 1 quarter. The position peaked at $6.14M in Q4 2025. 2,244 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

The Woodbridge Company reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
The Woodbridge Company sold 63,885 Medtronic shares in Q1 2026, an estimated $6.14M.
The Woodbridge Company first reported a position in Medtronic in Q4 2025 and held it in 1 quarter.
The Woodbridge Company's Medtronic position peaked at $6.14M in Q4 2025.
2,244 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on The Woodbridge Company's 13F filing for Q1 2026, filed 14 May 2026.